• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Gestational Diabetes Elevates Innate Lymphoid Cell Counts in Early Human Colostrum

by
November 18, 2026
in Biology
Reading Time: 6 mins read
0
Gestational Diabetes Elevates Innate Lymphoid Cell Counts in Early Human Colostrum

Gestational Diabetes Elevates Innate Lymphoid Cell Counts in Early Human Colostrum

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A prospective clinical investigation conducted at the University Medicine Greifswald has demonstrated that maternal gestational diabetes mellitus substantially alters the cellular immune composition of human colostrum by significantly increasing the absolute numbers of all three major subsets of innate lymphoid cells. Innate lymphoid cells, which belong to the CD45-positive leukocyte population, lack lineage-specific cell surface markers such as CD3, CD11b, CD11c, and CD19, and operate without antigen-specific receptors while providing vital early immune defense and tissue maintenance. When tracking maternal milk across early lactation, researchers observed that the absolute concentrations of breast milk innate lymphoid cells declined sharply over the first two weeks postpartum across all studied groups. Crucially, preterm birth did not alter the frequency or absolute cell counts of innate lymphoid cell subtypes across any sampled stage of lactation, demonstrating that gestational age at delivery does not drive differences in the cellular transfer of these maternal leukocytes to the newborn infant.

The study protocol, approved under ethics authorizations BB 026/18 and BB050/19 by the ethics committee of the University Medicine Greifswald, prospectively enrolled adult mothers admitted to the hospital maternity unit between August 2019 and November 2021. To dissect the distinct influences of gestational maturity and maternal metabolic status, the researchers structured the research across two separate cohorts. Cohort 1 evaluated breast milk specimens collected from 30 mothers delivering term and preterm infants to identify whether the timing of birth modifies innate lymphoid cell dynamics. Cohort 2 assessed breast milk samples obtained from 17 mothers with and without gestational diabetes mellitus who exclusively breastfed their term-born infants, while also pairing these samples with neonatal umbilical cord blood to evaluate downstream cellular communication. Mothers with clinical mastitis, delayed lactogenesis exceeding 72 hours postpartum, perinatal infections, or infants with severe congenital malformations or chromosomal disorders were systematically excluded from participation.

Standardized biological sample collections were scheduled across three defined physiological phases of early lactogenesis: day 3 postpartum representing colostrum, day 8 representing transitional milk, and day 13 representing early mature milk in term mothers and late transitional milk in preterm mothers. Participants expressed between 10 and 40 milliliters of milk, or 2 to 10 milliliters for colostrum collections, using an Amaryll manual breast pump between 8:00 AM and 10:00 AM during their initial morning lactation cycle. Trained study team members conducted home collections for participants discharged before day 3 postpartum. In parallel, maternal peripheral venous blood samples of approximately 6 milliliters were collected in EDTA tubes on the day of the first milk donation to evaluate whether systemic circulating immune profiles mirrored mammary cellular dynamics. Clinical records and standardized prenatal booklets provided maternal age, pre-pregnancy body mass index, gestational weight gain, glycated hemoglobin levels, comorbidities, and delivery mode.

To evaluate cell viability and immunophenotypic characteristics, breast milk samples were diluted 1:1 with phosphate-buffered saline, centrifuged at 600 times gravity for 20 minutes at 4 degrees Celsius, and separated from the lipid layer and aqueous supernatant before undergoing double washing in bovine serum albumin buffer. Maternal blood specimens underwent ammonium chloride-potassium lysis for 7 minutes to clear erythrocytes. Using a BD FACS LSRII flow cytometer and FACSDiva software, the research team implemented a rigorous gating strategy that excluded cell doublets, eliminated Trucount absolute counting beads from the viable gate, and identified living CD45-positive leukocytes using Zombie NIR dye. Innate lymphoid cells were classified as lineage-negative and CD127-positive. Subpopulations were resolved through distinct surface antigens: CD56 for type 1 innate lymphoid cells, CD294 for type 2 innate lymphoid cells, and CD117 with or without CD336 for type 3 innate lymphoid cells, verified against fluorescence minus one staining controls.

Across the first two weeks of lactation, flow cytometric quantification revealed a steep physiological reduction in total innate lymphoid cell counts in human breast milk. In Cohort 1, absolute cell numbers for ILC1, ILC2, and ILC3 subsets dropped significantly between day 3 colostrum, day 8 transitional milk, and day 13 early mature milk. When comparing mothers of preterm infants to mothers delivering at term, two-sample t-tests and median regression models adjusted for maternal age revealed no significant differences in either breast milk innate lymphoid cell numbers or maternal circulating blood frequencies at any sampled postpartum time point. These temporal reductions mirror the established physiological trajectory of overall human milk leukocytes, which typically constitute 13 to 70 percent of cellular content in colostrum before falling to less than 2 percent in mature milk, indicating that innate lymphoid cell clearance follows standard postnatal mammary gland remodeling.

In sharp contrast to gestational age, maternal gestational diabetes mellitus exerted a pronounced regulatory effect on the immunological cellular density of colostrum in Cohort 2. Mothers diagnosed with gestational diabetes exhibited significantly elevated absolute cell numbers of all three innate lymphoid cell classes in day 3 colostrum compared with normoglycemic control mothers, with specific significance levels reaching p = 0.0125 for ILC1, p = 0.0109 for ILC2, and p = 0.0085 for ILC3. Median regression models confirmed that the significant association between gestational diabetes and higher colostrum innate lymphoid cell counts persisted after adjusting for maternal age, pre-pregnancy body mass index, and gestational age. However, this metabolic disparity was transient: by day 8 transitional milk and day 13 mature milk, absolute cell counts and CD45-positive proportions no longer differed significantly between diabetic and healthy control mothers.

Analysis of systemic maternal blood collected on day 3 postpartum demonstrated that absolute numbers of circulating innate lymphoid cells were not significantly altered by gestational diabetes mellitus. However, the proportional frequency of CD45-positive ILC1 within maternal peripheral blood was significantly lower in the gestational diabetes group compared to normoglycemic control mothers, who exhibited higher relative ILC1 frequencies at p = 0.0408. When investigating maternal anthropometric variables through median regression models, pre-pregnancy body mass index displayed significant positive associations with colostrum ILC1 counts as well as maternal blood ILC2 mean values and ILC3 counts. Conversely, gestational weight gain showed a statistically significant negative association with ILC3 counts in colostrum, reflecting a broader clinical pattern where mothers with higher pre-pregnancy body mass index tended to gain less gestational weight.

To investigate whether breast milk innate lymphoid cells directly alter neonatal immune programming, the researchers collected 6 milliliters of umbilical cord blood at delivery, isolated peripheral blood mononuclear cells via Ficoll density gradients, and purified cord blood T cells using magnetic bead isolation to greater than 95 percent purity. T cells were seeded at 100,000 cells in X-Vivo medium supplemented with 1 microgram per milliliter of interleukin-2 and maintained in monoculture for 3 to 5 days. Upon receiving day 4 postpartum breast milk, maternal innate lymphoid cells were enriched to approximately 80 percent purity using pan-ILC and CD127 magnetic bead kits. The team then cultured two-thirds of the isolated maternal innate lymphoid cells with 100,000 autologous cord blood T cells for 24 hours at 37 degrees Celsius with 5 percent carbon dioxide, comparing marker expression directly against pure T cell monocultures maintained under identical conditions.

Immunophenotypic analysis revealed notable baseline differences in unmanipulated cord blood T cells between infants born to mothers with gestational diabetes and those born to healthy control mothers. In pure culture, cord blood T cells from gestational diabetes pregnancies displayed significantly higher proportions of cells expressing sphingosine-1-phosphate receptor 1 across CD3-positive T cells at p = 0.0104, CD3-positive CD8-positive T cells at p = 0.0169, and CD3-positive CD4-positive T cells at p = 0.0223. Baseline expression of cytotoxic T-lymphocyte-associated protein 4 on total CD3-positive T cells was also elevated in the gestational diabetes group at p = 0.0008, whereas the proportion of CTLA-4-positive CD8-positive T cells was significantly lower at p = 0.0063. Furthermore, both the proportion of programmed cell death protein 1 on CD8-positive T cells (p = 0.0017) and its median fluorescence intensity (p = 0.0276) were significantly decreased in the gestational diabetes cohort.

When neonatal T cells were placed into 24-hour co-culture with breast milk-derived innate lymphoid cells, maternal cells did not provoke or amplify pro-inflammatory activation phenotypes in neonatal lymphocytes. The elevated proportion of S1PR1-positive CD8-positive T cells seen in gestational diabetes samples exhibited a non-significant trend toward reduction from pure culture to co-culture (p = 0.0615), while S1PR1 median fluorescence intensity on CD4-positive T cells became significantly lower in gestational diabetes co-cultures compared to control co-cultures at p = 0.003. Interleukin-2 receptor alpha chain expression, marked by CD25, increased significantly on total CD3-positive T cells in the gestational diabetes group following co-culture (p = 0.047), and CD25-positive CD8-positive T cells were higher in gestational diabetes co-cultures than control co-cultures (p = 0.0234). However, other activation markers including CD69 remained unchanged, demonstrating that maternal milk cells do not trigger overt pro-inflammatory cascades.

Correlation analyses evaluating maternal age, pre-pregnancy body mass index, and gestational weight gain revealed no statistically significant relationships with the absolute or relative expression levels of PD-1, CD69, S1PR1, CD25, or CTLA-4 across neonatal CD3-positive, CD4-positive, or CD8-positive T-cell subsets in either clinical group. The authors emphasized several critical limitations inherent to their experimental design, most notably that all functional immunological assays were restricted to in vitro co-culture models using umbilical cord blood and cannot be directly extrapolated to in vivo physiological processes occurring within the gastrointestinal tract or systemic circulation of living infants. Additionally, substantial technical variability occurred in the yield of breast milk innate lymphoid cells available for co-culture experiments, ranging from 95 to 7,650 cells per condition with a mean of 2,853 cells. While statistical analyses indicated this cell count variation did not introduce systematic quantitative bias, the authors concluded that larger prospective in vivo investigations are necessary to clarify how maternal milk innate lymphoid cells modulate long-term neonatal metabolic and immunological development.

Subject of Research: Effects of gestational diabetes and preterm delivery on innate lymphoid cell populations in human breast milk and their in vitro interactions with neonatal cord blood T cells

Article Title: Effects of preterm birth and gestational diabetes on innate lymphoid cells (ILCs) in human breast milk

Article References: Raché, M., Lükewille, L., Vogelgesang, A., Lange, A., Ittermann, T., Heckmann, M., & Ruhnau, J. (2026). Effects of preterm birth and gestational diabetes on innate lymphoid cells (ILCs) in human breast milk. Molecular and Cellular Pediatrics, 13(1), Article 45. https://doi.org/10.1186/s40348-026-00255-y

Image Credits: AI Generated

DOI: 10.1186/s40348-026-00255-y

Keywords: gestational diabetes mellitus, innate lymphoid cells, human colostrum, breast milk immunology, preterm birth, cord blood T cells, transitional milk, S1PR1 expression, T cell activation markers, ILC1, ILC2, ILC3, flow cytometry, pre-pregnancy body mass index, gestational weight gain, in vitro co-culture, University Medicine Greifswald

News Source: Drew Townsend. (November 18, 2026). Gestational Diabetes Elevates Innate Lymphoid Cell Counts in Early Human Colostrum. Scienmag.

Tags: breast milk immunologycord blood T cellsflow cytometrygestational diabetes mellitusgestational weight gainhuman colostrumILC1ILC2ILC3in vitro co-cultureInnate lymphoid cellspre-pregnancy body mass indexPreterm BirthS1PR1 expressionT cell activation markerstransitional milkUniversity Medicine Greifswald
Share12Tweet7Share2ShareShareShare1

Related Posts

Data-Driven Dynamical Models Accurately Predict Social Decision-Making in Trust Games

Data-Driven Dynamical Models Accurately Predict Social Decision-Making in Trust Games

November 18, 2026
Phosphorylated Viral LEF-6 Drives RNA Polymerase Export to Activate Very Late Genes

Phosphorylated Viral LEF-6 Drives RNA Polymerase Export to Activate Very Late Genes

November 18, 2026

LcWRKY18 Represses Anthocyanin Biosynthesis During High Temperature Leaf Fading in Loropetalum

November 18, 2026

Community Mangrove Protection in Belize Could Safeguard Millions in Blue Carbon

November 18, 2026

POPULAR NEWS

  • Colonial Legacies and Environmental Shifts Drive Mesoamerican Zoonotic Disease Vulnerabilities

    Colonial Legacies and Environmental Shifts Drive Mesoamerican Zoonotic Disease Vulnerabilities

    29 shares
    Share 12 Tweet 7
  • Motor Imagery Vividness Shows No Link to Parkinson’s Motor Symptom Severity

    29 shares
    Share 12 Tweet 7
  • Brain Tumour Review Identifies Ferroptosis Checkpoints and Spatial Therapeutic Vulnerabilities

    29 shares
    Share 12 Tweet 7
  • Hepatitis C Vesicles Maintain Immunosuppressive Signals Despite Antiviral Cure in Cirrhosis

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Deep Learning Model Detects Common Poultry Diseases With 96.5 Percent Accuracy

Nearly Half of Chinese Pulse Diagnosis Terms Replaced Across WHO Standards

Reducing Sugar Systems Modulate Flavor and Maillard Pathways in Whole-Wheat Lye Bread

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.